Granite Investment Partners’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-530,923
Closed -$11.2M 268
2022
Q2
$11.2M Sell
530,923
-38,234
-7% -$780K 0.46% 88
2022
Q1
$13.4M Sell
569,157
-43,214
-7% -$1.06M 0.45% 91
2021
Q4
$16.7M Buy
612,371
+20,599
+3% +$551K 0.49% 84
2021
Q3
$16.8M Sell
591,772
-14,584
-2% -$444K 0.52% 82
2021
Q2
$18.3M Buy
606,356
+7,460
+1% +$220K 0.56% 71
2021
Q1
$15.3M Buy
+598,896
New +$15.3M 0.51% 83

Other funds holding MD

Granite Investment Partners's MD Position: Q3 2022 in Review

Granite Investment Partners sold out of Pediatrix Medical (MD) in Q3 2022, closing a stake of 530,923 shares — an estimated $11.2M sold.

Granite Investment Partners first reported a position in MD in Q1 2021 and held it in 6 quarters. The position peaked at $18.3M in Q2 2021. 211 funds tracked by Wall St. Rank hold MD as of Q3 2022.

  • Granite Investment Partners reported no remaining Pediatrix Medical position as of Q3 2022 after selling out during the quarter.
  • Granite Investment Partners sold 530,923 Pediatrix Medical shares in Q3 2022, an estimated $11.2M.
  • Granite Investment Partners first reported a position in Pediatrix Medical in Q1 2021 and held it in 6 quarters.
  • Granite Investment Partners's Pediatrix Medical position peaked at $18.3M in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2022.

Based on Granite Investment Partners's 13F filing for Q3 2022, filed 24 Oct 2022.